enzalutamide,talazoparib
astellas,pfizer
['talapro,2', 'talapro2']
 slide from during his excellent #asco23 discussion regarding subsequent #parp inhibitor in #talapro2 
Clinical researcher focused on #ProstateCancer, early recurrence (#BCR)  & #immunotherapy. Views are my own & do not represent the National Cancer Institute